IShares Nasdaq (UK) Performance
| BTEC Etf | 6.35 0.03 0.47% |
The etf retains a Market Volatility (i.e., Beta) of 0.16, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IShares Nasdaq's returns are expected to increase less than the market. However, during the bear market, the loss of holding IShares Nasdaq is expected to be smaller as well.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Nasdaq Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, IShares Nasdaq is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
IShares |
IShares Nasdaq Relative Risk vs. Return Landscape
If you would invest 623.00 in iShares Nasdaq Biotechnology on December 28, 2024 and sell it today you would earn a total of 12.00 from holding iShares Nasdaq Biotechnology or generate 1.93% return on investment over 90 days. iShares Nasdaq Biotechnology is generating 0.0358% of daily returns and assumes 1.0551% volatility on return distribution over the 90 days horizon. Simply put, 9% of etfs are less volatile than IShares, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
IShares Nasdaq Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Nasdaq's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as iShares Nasdaq Biotechnology, and traders can use it to determine the average amount a IShares Nasdaq's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0339
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BTEC |
Estimated Market Risk
| 1.06 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average IShares Nasdaq is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares Nasdaq by adding it to a well-diversified portfolio.
IShares Nasdaq Fundamentals Growth
IShares Etf prices reflect investors' perceptions of the future prospects and financial health of IShares Nasdaq, and IShares Nasdaq fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IShares Etf performance.
About IShares Nasdaq Performance
Assessing IShares Nasdaq's fundamental ratios provides investors with valuable insights into IShares Nasdaq's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the IShares Nasdaq is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.